Syngene International appoints Gaurav Kushwaha as new Chief Technology Officer

Published On 2025-07-29 10:00 GMT   |   Update On 2025-07-29 10:46 GMT
Advertisement

Syngene International has announced the appointment of Gaurav Kushwaha as the company's new Chief Technology Officer.

"We are delighted to welcome Gaurav Kushwaha as Syngene’s new Chief Technology Officer. We’re excited to have Gaurav on board and look forward to the innovation and transformation he will lead at Syngene," the company shared in a LinkedIn post.
Gaurav brings over 24 years of experience in IT and digital transformation across telecom, banking, defence, pharmaceuticals, and manufacturing. Throughout his career, he has leveraged technology to drive strategic business outcomes, delivering measurable impact on EBITDA and operational efficiencies.
Gaurav joins Synegene from Jubilant Ingrevia Limited where he served as a Chief Digital & Information Officer (CDIO). Prior to thathe held roles at Indus Towers Limited, Wipro Infotech, Comverse, Convergys, Tata Consultancy Services, and The Tata Power Company Ltd.
"Gaurav will lead the development and execution of our digital transformation strategy, driving smarter, faster and scalable operations across the entire value chain," Peter Bains, MD and CEO, Syngene.
Advertisement

Syngene International Ltd. is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. With 2.2 Mn sq. ft of specialized discovery, development, and manufacturing facilities, Syngene works with biotech companies pursuing leading-edge science as well as multinationals, including BMS, GSK, Zoetis and Merck KGaA.

Read also: Syngene International names Chethan Yogesh as Company Secretary, Compliance Officer

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News